Related references
Note: Only part of the references are listed.Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging
Wouter P. te Rijdt et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2019)
A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy
Julia Cadrin-Tourigny et al.
EUROPEAN HEART JOURNAL (2019)
Phospholamban cardiomyopathy: aCanadian perspective on aunique population
C. C. Cheung et al.
NETHERLANDS HEART JOURNAL (2019)
The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update
L. P. Bosman et al.
NETHERLANDS HEART JOURNAL (2019)
Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis
Laurens P. Bosman et al.
HEART RHYTHM (2018)
Effect of Ascertainment Bias on Estimates of Patient Mortality in Inherited Cardiac Diseases
Eline A. Nannenberg et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2018)
Sudden Cardiac Death in the Young
Michael Ackerman et al.
CIRCULATION (2016)
Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications
Louise R. A. Olde Nordkamp et al.
HEART RHYTHM (2016)
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
Gary S. Collins et al.
ANNALS OF INTERNAL MEDICINE (2015)
A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations
Grazyna T. Truszkowska et al.
BMC MEDICAL GENETICS (2015)
A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia
Guan-Sheng Liu et al.
CARDIOVASCULAR RESEARCH (2015)
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)
Silvia G. Priori et al.
EUROPEAN HEART JOURNAL (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Inherited Cardiomyopathies
Jeffrey A. Towbin
CIRCULATION JOURNAL (2014)
Outcome in Phospholamban R14del Carriers Results of a Large Multicentre Cohort Study
Ingrid A. W. van Rijsingen et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2014)
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)
Constantinos O'Mahony et al.
EUROPEAN HEART JOURNAL (2014)
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
Perry M. Elliott et al.
EUROPEAN HEART JOURNAL (2014)
Mortality of Inherited Arrhythmia Syndromes Insight Into Their Natural History
Eline A. Nannenberg et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2012)
Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy
Paul A. van der Zwaag et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Mutations in the human phospholamban gene in patients with heart failure
Alessandra Medeiros et al.
AMERICAN HEART JOURNAL (2011)
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia
Frank I. Marcus et al.
EUROPEAN HEART JOURNAL (2010)
Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes
Maximilian G. Posch et al.
HEART RHYTHM (2009)
A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy
K Haghighi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban
JP Schmitt et al.
SCIENCE (2003)
Share Paper
